002: The Biopharma Exit Strategy With Dr. Francois Nader
Business Of Biotech
00:00
The Importance of a Good Investor Scientist Relationship
The only common denominator is the need for capital. Not all VCs are created equal in the sense that based on their mission and their strategic every firm has a niche. But I think the practical challenge of a scientist is to determine who to work with and which doors on which to not. It might sound trivial, but it's not because see this investor scientist relationship is just like a marriage, very easy to get in, extremely difficult to get out of it.
Play episode from 11:29
Transcript
